Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2022-04-25	Taiwan-developed herbal COVID drug works for kids too	Taiwan News
2022-04-21	Quarantine-free entry into Taiwan possible in July: Health minister	Radio Taiwan International
2022-04-18	Orient EuroPharma gains rights to Contrave for Taiwan	BioSpectrum Asia
2022-04-18	Lotus received approval for Alymsys®, a biosimilar to Avastin® (bevacizumab), in Taiwan	Press Release
2022-04-15	SyneuRx completes enrolment in Phase II trial of Covid-19 oral antiviral	Clinical Trials Arena
2022-04-13	Biochemist Chi-Huey Wong receives US ‘Pioneer’ award	Taipei Times
2022-04-12	Fifty-five drug shortages reported in first two months	Taipei Times
2022-04-12	CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants	Press Release
2022-04-11	Ontario Together Fund invests $1.9M in Bora Pharmaceutical Services	Canadian Manufacturing
2022-04-11	OBI PHARMA ANNOUNCES POSTER PRESENTATIONS AT AACR 2022 ANNUAL MEETING FOR OBI-3424 AND GLOBO H SCIENCE	Press Release

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978